Boehringer Ingelheim International GmbHDirector, Preclinical PKPD Modeling Boehringer Ingelheim International GmbHDirector, Preclinical PKPD ModelingRidgefield, CT$250,000–$394,000 / yearPhD in related field or equivalent area of focus with a minimum of 6 years relevant experience in Pharmacometrics / Preclinical PKPD Modelling in the pharmaceutical industry, regulatory agencies, or academia • Master's degree in in related field medicine or equivalent area of focus with a minimum of 8 years relevant experience in Pharmacometrics / Preclinical PKPD Modelling in the pharmaceutical industry, regulatory agencies, or academia • Professional degree in pharmacy or medicine (e.g., PharmD, MD, Apotheker, Arzt) with a minimum of 7 years relevant experience in Pharmacometrics / Preclinical PKPD Modelling in the pharmaceutical industry, regulatory agencies, or academia • Minimum of 4 years' relevant experience in working in drug discovery teams preferred • Proficiency in applying PMx/PKPD/QSP modeling with impact on decision making. In depth scientific and strategic knowledge in the field and knowledge of overall drug discovery process • Ability to inspire and motivate a team and focus their energy on achieving business goals • Process and performance-oriented, constant drive to develop and implement innovative approaches and processes • Ability to challenge processes and procedures, propose changes, and perform contributions to problem solving • Excellent communication skills, with a strong publication and presentation record.
Boehringer IngelheimDirector, Preclinical PKPD Modeling Boehringer IngelheimDirector, Preclinical PKPD ModelingRidgefield, CT$250,000–$394,000 / yearBuild strong partnerships with Discovery Research, Clinical Pharmacology, Biotherapeutics Discovery, and other internal and external stakeholders to ensure seamless integration of modeling expertise across our therapeutic areas (e.g., Immunology & Respiratory, Cardio-Renal-Metabolic, and Oncology Discovery Research). You will lead, inspire, and develop the Ridgefield PK/PD modeling team, represent the local Team in a global setting, and collaborate across disciplines to deliver high-quality translational strategies resulting in model-informed human efficacious dose predictions across our portfolio.
Synchrony BankNewAVP, Acquisition Fraud Strategy and Model Monitoring Synchrony BankAVP, Acquisition Fraud Strategy and Model MonitoringConnecticutBachelor’s degree and 5+ years of experience building analytically derived strategies within Credit, Marketing, Risk or Collections in Financial services, or in lieu of a Bachelor's degree, 9+ years of experience building analytically derived strategies in Marketing, Risk or Collections in Financial services. . Partner with portfolio credit managers and client teams to launch new initiatives, communicate changes in a timely & effective manner, and ensure strategies are driving the desired P&L impacts .
Cloverleaf BioScientist, Cancer Modeling Cloverleaf BioScientist, Cancer ModelingNew Haven, CTYour responsibilities will include designing and executing in house animal experiments in mice, proposing, planning and coordinating toxicity, pharmacology and efficacy studies at CROs, performing cell culture experiments with lead candidate RNAs to predict in vivo outcomes, and providing in vivo pharmacology and physiology expertise to accelerate development of our tRNA therapeutics. Cloverleaf's approach to drugging tRNA modifying enzymes uses engineered “trojan horse” tRNAs to modulate translation in cancerous cells.